Rifabutin
Rifabutin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Prophylaxis of Mycobacterium avium complex (MAC) in patients with AIDS.
- Treatment of H. pylori infections in combination with other agents.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of disseminated MAC in patients with AIDS (in combination with a macrolide plus ethambutol).
- Treatment of TB in patients with AIDS who are taking PIs or NNRTIs.
- Treatment of latent TB in patients intolerant to INH. Rifabutin x 4 months can be considered.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Prophylaxis of Mycobacterium avium complex (MAC) in patients with AIDS.
- Treatment of H. pylori infections in combination with other agents.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of disseminated MAC in patients with AIDS (in combination with a macrolide plus ethambutol).
- Treatment of TB in patients with AIDS who are taking PIs or NNRTIs.
- Treatment of latent TB in patients intolerant to INH. Rifabutin x 4 months can be considered.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved